Le produit a bien été ajouté au panier.

discount label
LCBiot-VLDFAPPGA-OH
Vue en 3D

Biosynth logo

LCBiot-VLDFAPPGA-OH

Ref. 3D-PP49158

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 3 décembre 2024

Informations sur le produit

Nom :
LCBiot-VLDFAPPGA-OH
Description :

Peptide LCBiot-VLDFAPPGA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-VLDFAPPGA-OH include the following: Proteolysis-targeting chimeras enhance T cell bispecific antibody-driven T cell activation and effector function through increased MHC class I antigen presentation in V Massafra, S Tundo, A Dietzig, A Ducret - The Journal of , 2021 - journals.aai.orghttps://journals.aai.org/jimmunol/article/207/2/493/234652 Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4+ and CD8+ memory formation S Schmied, E Gostick, DA Price, H Abken - , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.12472 Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA"‘A2"‘restricted WT1"‘reactive CD8+ T cells S Kan, T Bito, M Shimabuku - International , 2020 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/ijo.2020.5110 WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma RA van Amerongen, RS Hagedoorn - for Immunotherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214430/ Mechanism of action of DSP-7888 (adegramotide/nelatimotide) Emulsion, a peptide-based therapeutic cancer vaccine with the potential to turn up the heat on non N Suginobe, M Nakamura, Y Takanashi, H Ban - Clinical and , 2023 - Springerhttps://link.springer.com/article/10.1007/s12094-022-02946-0 Clinical grade production of wilms' tumor-1 loaded cord blood-derived dendritic cells to prevent relapse in pediatric AML after cord blood transplantation M Plantinga, V Lo Presti, CG de Haar - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.559152 Sub-ambient pressure IR-MALDI ion mobility spectrometer for the determination of low and high field mobilities J Villatoro , M Zuhlke, D Riebe , T Beitz, M Weber - Analytical and , 2020 - Springerhttps://link.springer.com/article/10.1007/s00216-020-02735-0 Generation of WT1 peptide-specific T-cells out of healthy volunteer donors for adoptive immunotherapy after allogeneic stem cell transplantation G Weber, J Karbach, S Kuci, H Kreyenberg - Bone Marrow , 2009 - go.gale.comhttps://go.gale.com/ps/i.do?id=GALE%7CA198170695&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=02683369&p=AONE&sw=w Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells FS Lichtenegger, M Rothe, FM Schnorfeil - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.00385/full CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function E Ruggiero, E Carnevale, A Prodeus - Science Translational , 2022 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.abg8027 The physiological interactome of TCR-like antibody therapeutics in human tissues E Marrer-Berger, A Nicastri, A Augustin - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41467-024-47062-5 A de-risking experimental framework defines the physiological interactome of TCR-based therapeutics in human tissues E Marrer-Berger, A Nicastri , A Augustin, V Pulko - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1828302/latest Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias E Doubrovina, T Carpenter, D Pankov - Blood, The Journal , 2012 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/120/8/1633/30848 CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins C Jost, D Darowski, J Challier, V Pulko, LJ Hanisch - MAbs, 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2020.1840709

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP49158 LCBiot-VLDFAPPGA-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".